These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26856827)

  • 1. Escape Mutations in NS4B Render Dengue Virus Insensitive to the Antiviral Activity of the Paracetamol Metabolite AM404.
    van Cleef KW; Overheul GJ; Thomassen MC; Marjakangas JM; van Rij RP
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2554-7. PubMed ID: 26856827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
    van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP
    Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue virus is sensitive to inhibition prior to productive replication.
    Talemi SR; Bartenschlager M; Schmid B; Ruggieri A; Bartenschlager R; Höfer T
    Cell Rep; 2021 Oct; 37(2):109801. PubMed ID: 34644578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
    Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase.
    Kato F; Nio Y; Yagasaki K; Suzuki R; Hijikata M; Miura T; Miyazaki I; Tajima S; Lim CK; Saijo M; Takasaki T; Hishiki T
    Antiviral Res; 2019 Dec; 172():104643. PubMed ID: 31678478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting dengue virus NS4B protein for drug discovery.
    Xie X; Zou J; Wang QY; Shi PY
    Antiviral Res; 2015 Jun; 118():39-45. PubMed ID: 25796970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dengue virus by targeting viral NS4B protein.
    Xie X; Wang QY; Xu HY; Qing M; Kramer L; Yuan Z; Shi PY
    J Virol; 2011 Nov; 85(21):11183-95. PubMed ID: 21865382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction.
    Kaptein SJF; Goethals O; Kiemel D; Marchand A; Kesteleyn B; Bonfanti JF; Bardiot D; Stoops B; Jonckers THM; Dallmeier K; Geluykens P; Thys K; Crabbe M; Chatel-Chaix L; Münster M; Querat G; Touret F; de Lamballerie X; Raboisson P; Simmen K; Chaltin P; Bartenschlager R; Van Loock M; Neyts J
    Nature; 2021 Oct; 598(7881):504-509. PubMed ID: 34616043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication.
    Chatel-Chaix L; Fischl W; Scaturro P; Cortese M; Kallis S; Bartenschlager M; Fischer B; Bartenschlager R
    J Virol; 2015 Jul; 89(14):7170-86. PubMed ID: 25926641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of a stable luciferase dengue virus for high-throughput screening.
    Zou G; Xu HY; Qing M; Wang QY; Shi PY
    Antiviral Res; 2011 Jul; 91(1):11-9. PubMed ID: 21575658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K48-linked polyubiquitination of dengue virus NS1 protein inhibits its interaction with the viral partner NS4B.
    Giraldo MI; Vargas-Cuartas O; Gallego-Gomez JC; Shi PY; Padilla-Sanabria L; Castaño-Osorio JC; Rajsbaum R
    Virus Res; 2018 Feb; 246():1-11. PubMed ID: 29294313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel Dengue-1 virus replicon system expressing secretory Gaussia luciferase for analysis of viral replication and discovery of antiviral drugs.
    Kato F; Kobayashi T; Tajima S; Takasaki T; Miura T; Igarashi T; Hishiki T
    Jpn J Infect Dis; 2014; 67(3):209-12. PubMed ID: 24858611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dengue virus replicons: production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirin's activity.
    Massé N; Davidson A; Ferron F; Alvarez K; Jacobs M; Romette JL; Canard B; Guillemot JC
    Antiviral Res; 2010 Jun; 86(3):296-305. PubMed ID: 20307577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue virus NS4B protein as a target for developing antivirals.
    Li Q; Kang C
    Front Cell Infect Microbiol; 2022; 12():959727. PubMed ID: 36017362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of Putative N-Glycosylation Sites on Dengue Virus NS4B Decreases RNA Replication.
    Naik NG; Wu HN
    J Virol; 2015 Jul; 89(13):6746-60. PubMed ID: 25878113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies.
    Arora R; Liew CW; Soh TS; Otoo DA; Seh CC; Yue K; Nilar S; Wang G; Yokokawa F; Noble CG; Chen YL; Shi PY; Lescar J; Smith TM; Benson TE; Lim SP
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32907977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Small-Molecule Oligosaccharyltransferase Inhibitor with Pan-flaviviral Activity.
    Puschnik AS; Marceau CD; Ooi YS; Majzoub K; Rinis N; Contessa JN; Carette JE
    Cell Rep; 2017 Dec; 21(11):3032-3039. PubMed ID: 29241533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Compound-B, a novel anti-dengue virus agent targeting the non-structural protein 4A.
    Nobori H; Toba S; Yoshida R; Hall WW; Orba Y; Sawa H; Sato A
    Antiviral Res; 2018 Jul; 155():60-66. PubMed ID: 29758236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4.
    Hanley KA; Manlucu LR; Gilmore LE; Blaney JE; Hanson CT; Murphy BR; Whitehead SS
    Virology; 2003 Jul; 312(1):222-32. PubMed ID: 12890635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic surveillance reveals a dengue 2 virus epidemic lineage with a marked decrease in sensitivity to Mosnodenvir.
    Bouzidi HS; Sen S; Piorkowski G; Pezzi L; Ayhan N; Fontaine A; Canivez T; Geulen M; Amaral R; Grard G; Durand GA; de Lamballerie X; Touret F; Klitting R
    Nat Commun; 2024 Oct; 15(1):8667. PubMed ID: 39384752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.